Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study
Open accessAbstract
OBJECTIVES: Very few studies have investigated clinical features associated with treatment-resistant depression (TRD) defined as failure of at least 2 consecutive antidepressant trials. The primary objective of this multicenter study was to identify specific clinical and demographic factors associated with TRD in a large sample of patients with major depressive episodes that failed to reach response or remission after at least 2 consecutive adequate antidepressant treatments. METHOD: A total of 702 patients with DSM-IV major depressive disorder, recruited from January 2000 to February 2004, were included in the analysis. Among them, 346 patients were considered as nonresistant. The remaining 356 patients were considered as resistant, with a 17-item Hamilton Rating Scale for Depression score remaining greater than or equal to 17 after 2 consecutive adequate antidepressant trials. Cox regression models were used to examine the association between individual clinical variables and TRD. RESULTS: Among the clinical features investigated, 11 variables were found to be associated with TRD. We found anxiety comorbidity (p < .001, odds ratio [OR] = 2.6), comorbid panic disorder (p < .001, OR = 3.2) and social phobia (p = .008, OR = 2.1), personality disorder (p = .049, OR = 1.7), suicidal risk (p = .001, OR = 2.2), severity (p = .001, OR = 1.7), melancholia (p = .018, OR = 1.5), a number of hospitalizations > 1 (p = .003, OR = 1.6), recurrent episodes (p = .009, OR = 1.5), early age at onset (p = .009, OR = 2.0), and nonresponse to the first antidepressant received lifetime (p = .019, OR = 1.6) to be the factors associated with TRD. CONCLUSIONS: Our findings provide a set of 11 relevant clinical variables associated with treatment resistance in major depressive disorder that can be explored at the clinical level. The statistical model used in this analysis allowed for a hierarchy of these variables (based on the OR) showing that comorbid anxiety disorder is the most powerful clinical factor associated with TRD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Comorbid SAD in pharmacotherapy studies is associated with a poorer course of illness, treatment-resistant depression, and a greater number and earlier onset of depressive recurrences compared with patients without comorbid SAD.
“This comorbidity pattern may also affect treatment outcomes, with pharmacotherapy studies indicating that comorbid SAD is associated with a poorer course of illness (Mulder, Joyce, Frampton, Luty, & Sullivan, 2006), treatment-resistant depression (Souery et al., 2007), and a greater number and earlier onset of depressive recurrences compared with patients without comorbid SAD (Holma, Holma, Melart”
From An Integrated, Acceptance-Based Behavioral Approach for Depression With Social Anxiety: Preliminary Results (2014) · cites this paper as Souery et al., 2007
Prevalence estimates for treatment resistant schizophrenia, depression, and OCD range from 20% to 60% of people with the condition.
“Prevalence estimates of TRS, TRD, and treatment resistant OCD vary from 20-60% of the population with the condition. 26, 35–40”
From Treatment resistance in psychiatry: state of the art and new directions (2022) · cites this paper as [39]
Timing may add heterogeneous features: some individuals may change readily for certain symptoms, while others may have opposite tendencies.
“Timing may add heterogeneous features: certain individuals may change readily with respect to certain symptoms, whereas other subjects may have opposite tendencies [41].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [41]
The basic flaw is to assume improvement is a unitary phenomenon.
“The basic flaw is to assume improvement to be a unitary phenomenon [41].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [41]
Comorbidities such as substance use disorder can undermine previously effective maintenance therapy.
“Comorbidities such as substance use disorder can undermine previously effective maintenance therapy [18]”
Approximately only one in two patients with major depressive disorder respond to their antidepressant treatment.
“Approximately only one in two patients with major depressive disorder (MDD) respond to their antidepressant treatment ( Rush et al., 2006 , Souery et al., 2007 , Thomas et al., 2013 )”
From Self-blame-selective hyper-connectivity between anterior temporal and subgenual cortices predicts prognosis in major depressive disorder (2023) · cites this paper as Souery et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83296-8 · Cited by 3,513 · see citing works
Self-citationSheehan, D., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller, E., Keskiner, A., Schinka, J., Knapp, E., Sheehan, M., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83297-x · Cited by 2,149 · see citing works
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422 · see citing works
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · see citing works
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · see citing works
(1997) · PubMed · Cited by 727 · see citing works
Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689 · see citing works
Treatment resistant depression: methodological overview and operational criteria
Souery, D., Amsterdam, J. D., de Montigny, C., Lecrubier, Y., Montgomery, S., Lipp, O., Racagni, G., Zohar, J., & Mendlewicz, J. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00004-2 · Cited by 443 · see citing works
Self-citationStimpson, N. J., Agrawal, N., & Lewis, G. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.4.284 · Cited by 159 · see citing works
Is treatment-resistant depression a unique subtype of depression?
Fagiolini, A. M., & Kupfer, D. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01670-0 · Cited by 141 · see citing works
Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials
Khan, A., Brodhead, A. E., Kolts, R. L., & Brown, W. A. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.06.005 · Cited by 115 · see citing works
Anxious Depression in Elderly Patients: Response to Antidepressant Treatment
Flint, A. J., & Rifat, S. L. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700520-00003 · Cited by 113 · see citing works
Empirical Testing of Two Models for Staging Antidepressant Treatment Resistance
Petersen, T., Papakostas, G. I., Posternak, M. A., Kant, A. J., Guyker, W. M., Iosifescu, D. V., Yeung, A., Nierenberg, A. A., & D, M. F. M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169036.40755.16 · Cited by 110 · see citing works
Cognitive-Behavioral Management of Drug-Resistant Major Depressive Disorder
Fava, G. A., Savron, G., Grandi, S., & Rafanelli, C. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0608b · Cited by 92 · see citing works
Predictors of response to antidepressants
Nierenberg, A. A. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00105-3 · Cited by 84 · see citing works
McPherson, S., Cairns, P., Carlyle, J., Shapiro, D. A., Richardson, P., & Taylor, D. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00498.x · Cited by 66 · see citing works
Predictors of response to treatment in children and adolescents with mood disorders
Emslie, G. J., Mayes, T. L., Laptook, R. S., & Batt, M. M. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00110-7 · Cited by 64 · see citing works
Comorbidity and depression treatment
Krishnan, K. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01787-0 · Cited by 58 · see citing works
Sherbourne, C., Schoenbaum, M., Wells, K. B., & Croghan, T. W. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2003.08.009 · Cited by 47 · see citing works
How accurate are patients in reporting their antidepressant treatment history?
Posternak, M. A., & Zimmerman, M. A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00049-6 · Cited by 34 · see citing works
Anxious Depression in Elderly Patients: Response to Antidepressant Treatment
Flint, A. J., & Rifat, S. L. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199721520-00003
Flagged first, then by citations
Research works printed but not linked: 1
- a Copyright Daniel Souery, M.D. early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2004;55:875-881
Cited by
Sorted by citations
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842 · see citing works
“Despite much investigation, consistent empirical associations between melancholic features and superior response to antidepressant medication have not been established (Dodd and Berk, 2004; Georgotas et al., 1986; Mallinckrodt et al., 2005; Nierenberg, 2003; Peselow et al., 1992; Souery et al., 2007; Trivedi et al., 2…”
BackgroundMcIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836 · see citing works
Self-citationA Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300059 · Cited by 580 · see citing works
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519 · see citing works
Defining treatment‐resistant depression
Gaynes, B. N., Lux, L., Gartlehner, G., Asher, G., Forman‐Hoffman, V., Green, J., Boland, E., Weber, R. P., Randolph, C., Bann, C., et al. (2020) · Depression and Anxiety · doi:10.1002/da.22968 · Cited by 447 · see citing works
<p>Management of Treatment-Resistant Depression: Challenges and Strategies</p>
Voineskos, D., Daskalakis, Z. J., & Blumberger, D. M. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s198774 · Cited by 446 · see citing works
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482 · see citing works
Self-citationTreatment resistance in psychiatry: state of the art and new directions
Howes, O. D., Thase, M. E., & Pillinger, T. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01200-3 · Cited by 413 · see citing works
Porcelli, S., Fabbri, C., & Serretti, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.10.003 · Cited by 331 · see citing works
Self-citationComorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment
Choi, K. W., Kim, Y., & Jeon, H. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9705-0_14 · Cited by 318 · see citing works
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Browne, C. A., & Lucki, I. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00161 · Cited by 285 · see citing works
McAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278 · see citing works
Self-citationIsingrini, E., Camus, V., Le Guisquet, A.-M., Pingaud, M., Devers, S., & Belzung, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010404 · Cited by 277 · see citing works
Dong, M., Zeng, L.-N., Lu, L., Li, X.-H., Ungvari, G. S., Ng, C. H., Chow, I. H. I., Zhang, L., Zhou, Y., & Xiang, Y.-T. (2019) · Psychological Medicine · doi:10.1017/s0033291718002301 · Cited by 263 · see citing works
The severity of psychiatric disorders
Zimmerman, M., Morgan, T. A., & Stanton, K. (2018) · World Psychiatry · doi:10.1002/wps.20569 · Cited by 227 · see citing works
Carlo, V. D., Calati, R., & Serretti, A. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.034 · Cited by 219 · see citing works
Self-citationStaging methods for treatment resistant depression. A systematic review
Ruhé, H. G., van Rooijen, G., Spijker, J., Peeters, F. P. M. L., & Schene, A. H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.020 · Cited by 210 · see citing works
Cai, H. X., Xie, X.-M., Zhang, Q., Cui, X., Lin, J.-X., Sim, K., Ungvari, G. S., Zhang, L., & Xiang, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.690130 · Cited by 217 · see citing works
Sforzini, L., Worrell, C., Kose, M., Anderson, I. M., Aouizerate, B., Arolt, V., Bauer, M., Baune, B. T., Blier, P., Cleare, A. J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01381-x · Cited by 214 · see citing works
Impact of pain on the course of depressive and anxiety disorders
Gerrits, M. M. J. G., Vogelzangs, N., van Oppen, P., van Marwijk, H. W. J., van der Horst, H., & Penninx, B. W. J. H. (2012) · Pain · doi:10.1016/j.pain.2011.11.001 · Cited by 199 · see citing works
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197 · see citing works
Hennings, J. M., Owashi, T., Binder, E. B., Horstmann, S., Menke, A., Kloiber, S. M., Dose, T., Wollweber, B., Spieler, D., Messer, T., et al. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.05.002 · Cited by 191 · see citing works
Eisendrath, S. J., Gillung, E., Delucchi, K. L., Segal, Z. V., Nelson, J. C., McInnes, L. A., Mathalon, D. H., & Feldman, M. D. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000442260 · Cited by 187 · see citing works
Pizzagalli, D. A., Webb, C. A., Dillon, D. G., Tenke, C. E., Kayser, J., Goer, F., Fava, M., McGrath, P., Weissman, M., Parsey, R., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0252 · Cited by 189 · see citing works
El-Khalili, N., Joyce, M. A., Atkinson, S. D., Buynak, R. J., Datto, C. J., Lindgren, P., & Eriksson, H. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000015 · Cited by 184 · see citing works
Gender differences in antidepressant drug response
Keers, R., & Aitchison, K. J. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.496448 · Cited by 183 · see citing works
Prevalence of treatment-resistant depression in primary care: cross-sectional data
Thomas, L., Kessler, D., Campbell, J., Morrison, J., Peters, T. J., Williams, C., Lewis, G., & Wiles, N. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x675430 · Cited by 175 · see citing works
Identifying fast-onset antidepressants using rodent models
Ramaker, M. J., & Dulawa, S. C. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.36 · Cited by 181 · see citing works
Ionescu, D. F., Bentley, K. H., Eikermann, M., Taylor, N., Akeju, O., Swee, M. B., Pavone, K. J., Petrie, S. R., Dording, C., Mischoulon, D., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.037 · Cited by 179 · see citing works
Kemp, A. H., Gordon, E., Rush, A. J., & Williams, L. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900017120 · Cited by 170 · see citing works
Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study
Webb, C. A., Trivedi, M. H., Cohen, Z. D., Dillon, D. G., Fournier, J. C. J., Goer, F., D, M. F. M., McGrath, P. J., Weissman, M. M., Parsey, R. V., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718001708 · Cited by 172 · see citing works
Reynolds, C. F., Butters, M. A., Lopez, O., Pollock, B. G., Dew, M. A., Mulsant, B. H., Lenze, E. J., Holm, M., Rogers, J. C., Mazumdar, S., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.184 · Cited by 171 · see citing works
Effectiveness of psychoeducation for depression: A systematic review
Tursi, M. F. D. S., Baes, C. V. W., Camacho, F. R. D. B., Tofoli, S. M. D. C., & Juruena, M. F. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413491154 · Cited by 173 · see citing works
Lundberg, J., Cars, T., Lööv, S., Söderling, J. K., Sundström, J., Tiihonen, J., Levál, A., Gannedahl, A., Björkholm, C., Själin, M., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.3860 · Cited by 168 · see citing works
Bartova, L., Dold, M., Kautzky, A., Fabbri, C., Spies, M., Serretti, A., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., et al. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1635270 · Cited by 152 · see citing works
Self-citationFrank, E., Cassano, G., Rucci, P., Thompson, W. K., KRAEMER, H. C., Fagiolini, A. M., Maggi, L., Kupfer, D. J., Shear, M. K., Houck, P. R., et al. (2010) · Psychological Medicine · doi:10.1017/s0033291710000553 · Cited by 151 · see citing works
Kautzky, A., Dold, M., Bartova, L., Spies, M., Kranz, G. S., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Fabbri, C., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12959 · Cited by 148 · see citing works
Self-citationTreatment-Resistant Depression in Primary Care across Canada
Rizvi, S. J., Grima, E., Tan, M., Rotzinger, S., Lin, P., McIntyre, R. S., & Kennedy, S. H. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900702 · Cited by 144 · see citing works
Mendlewicz, J. (2009) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802503086 · Cited by 143 · see citing works
Self-citationTreatment-resistant depression: are animal models of depression fit for purpose?
Willner, P., & Belzung, C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4034-7 · Cited by 140 · see citing works
Risk factors for treatment resistance in unipolar depression: A systematic review
Bennabi, D., Aouizerate, B., El‐Hage, W., Doumy, O., Molière, F., Courtet, P., Nieto, I., Bellivier, F., Bubrovsky, M., Vaïva, G., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.020 · Cited by 142 · see citing works
Schosser, A., Serretti, A., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., & Kasper, S. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.02.006 · Cited by 136 · see citing works
Self-citationDold, M., Bartova, L., Souery, D., Mendlewicz, J., Serretti, A., Porcelli, S., Zohar, J., Montgomery, S., & Kasper, S. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.02.020 · Cited by 131 · see citing works
Self-citationBareš, M., Brunovský, M., Kopeček, M., Novák, T., Stopková, P., Kožený, J., Šóš, P., Krajča, V., & Höschl, C. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.03.001 · Cited by 132 · see citing works
Craighead, W. E., & Dunlop, B. W. (2011) · Annual Review of Psychology · doi:10.1146/annurev.psych.121208.131653 · Cited by 129 · see citing works
Wiles, N., Thomas, L., Abel, A., Barnes, M., Carroll, F., Ridgway, N., Sherlock, S., Turner, N., Button, K., Odondi, L., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18310 · Cited by 127 · see citing works
Evidence-based pharmacotherapy of treatment-resistant unipolar depression
Dold, M., & Kasper, S. F. (2016) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2016.1248852 · Cited by 121 · see citing works
Self-citationSouery, D., Serretti, A., Calati, R., Oswald, P., Massat, I., Konstantinidis, A., Linotte, S., Bollen, J., Demyttenaere, K., Kasper, S. F., et al. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182228619 · Cited by 118 · see citing works
Self-citationLymphoblastoid Cell Lines in Pharmacogenomic Discovery and Clinical Translation
Wheeler, H. E., & Dolan, M. E. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.121 · Cited by 113 · see citing works
Mechanisms of antidepressant resistance
El-Hage, W., Leman, S., Camus, V., & Belzung, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00146 · Cited by 111 · see citing works
A transdiagnostic network for psychiatric illness derived from atrophy and lesions
Taylor, J. J., Lin, C., Talmasov, D., Ferguson, M. A., Schaper, F. L. W. V. J., Jiang, J., Goodkind, M. S., Grafman, J. H., Etkin, A., Siddiqi, S., et al. (2023) · Nature Human Behaviour · doi:10.1038/s41562-022-01501-9 · Cited by 107 · see citing works
Sackeim, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., Demitrack, M. A., George, M. S., Prudic, J., Thase, M. E., & Rush, A. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.021 · Cited by 109 · see citing works
The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review
Demyttenaere, K., & Van Duppen, Z. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy052 · Cited by 98 · see citing works
Self-citationNovel drug developmental strategies for treatment‐resistant depression
Borbély, É., Simon, M., Fuchs, E., Wiborg, O., Czéh, B., & Helyes, Z. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15753 · Cited by 111 · see citing works
Major depression: the importance of clinical characteristics and treatment response to prognosis
Katon, W. J., Unützer, J., & Russo, J. E. (2009) · Depression and Anxiety · doi:10.1002/da.20613 · Cited by 109 · see citing works
Paolucci, S., Iosa, M., Coiro, P., Venturiero, V., Savo, A., Angelis, D. D., & Morone, G. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00926 · Cited by 107 · see citing works
Tadić, A., Wagner, S., Höch, J., Başkaya, Ö., von Cube, R., Skaletz, C., Lieb, K., & Dahmen, N. (2009) · Psychopathology · doi:10.1159/000224149 · Cited by 103 · see citing works
Balestri, M., Calati, R., Souery, D., Kautzky, A., Kasper, S. F., Montgomery, S., Zohar, J., Mendlewicz, J., & Serretti, A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.033 · Cited by 105 · see citing works
Self-citationTherapeutic options in treatment-resistant depression
Vieta, E., & Colom, F. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.583675 · Cited by 100 · see citing works
Bennabi, D., Charpeaud, T., Yrondi, A., Genty, J., Destouches, S., Lancrenon, S., Allaïli, N., Bellivier, F., Bougerol, T., Camus, V., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2237-x · Cited by 101 · see citing works
Lai, C., Hsu, Y.-Y., & Wu, Y. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.06.002 · Cited by 100 · see citing works
Divergent outcomes in cognitive-behavioral therapy and pharmacotherapy for adult depression
Vittengl, J. R., Jarrett, R. B., Weitz, E., Hollon, S. D., Twisk, J., Cristea, I., David, D., DeRubeis, R. J., Dimidjian, S., Dunlop, B. W., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040492 · Cited by 97 · see citing works
Fleck, M. P. D. A., Berlim, M. T., Lafer, B., Sougey, É. B., Porto, J. A. D., Brasil, M. A. A., Juruena, M. F., & Hetem, L. A. (2009) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462009000500003 · Cited by 101 · see citing works
Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse
Iovieno, N., van Nieuwenhuizen, A., Clain, A., Baer, L., & Nierenberg, A. A. (2011) · Depression and Anxiety · doi:10.1002/da.20768 · Cited by 98 · see citing works
Neurogenesis and antidepressant action
Park, S. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03043-5 · Cited by 99 · see citing works
Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Reutfors, J., Andersson, T. M.-L., Brenner, P., Brandt, L., DiBernardo, A., Li, G., Hägg, D., Wingård, L., & Bodén, R. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.030 · Cited by 94 · see citing works
Bareš, M., Brunovský, M., Novák, T., Kopeček, M., Stopková, P., Šóš, P., Krajča, V., & Höschl, C. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.03.007 · Cited by 94 · see citing works
Zhang, C., Li, Z., Wu, Z., Chen, J., Wang, Z., Peng, D., Hong, W., Yuan, C., Wang, Z., Yu, S., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3297-0 · Cited by 93 · see citing works
Scott, F., Hampsey, E., Gnanapragasam, S., Carter, B., Marwood, L., Taylor, R. W., Emre, C., Korotkova, L., Martín-Dombrowski, J., Cleare, A. J., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811221104058 · Cited by 87 · see citing works
Kautzky, A., Baldinger, P., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Serretti, A., Lanzenberger, R. R., & Kasper, S. F. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.001 · Cited by 92 · see citing works
Self-citationPersistence and remission of ADHD during adulthood: a 7-year clinical follow-up study
Karam, R. G., Breda, V., Picon, F. A., Rovaris, D. L., Victor, M. M., Salgado, C. A. I., Vitola, E. S., Silva, K. L., Guimarães-da-Silva, P. O., Mota, N. R., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291714003183 · Cited by 113 · see citing works
Effects of illness duration and treatment resistance on grey matter abnormalities in majordepression
Serra-Blasco, M., Portella, M. J., Gómez-Ansón, B., de Diego-Adeliño, J., Vives-Gilabert, Y., Puigdemont, D., Granell, E., Santos, A., Álvarez, E., & Pérez, V. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.116228 · Cited by 87 · see citing works
The impact of Ayahuasca on suicidality: results from a randomized controlled trial
Zeifman, R. J., Palhano-Fontes, F., Hallak, J., Arcoverde, E., Maia-Oliveira, J. P., & Araujo, D. B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01325 · Cited by 87 · see citing works
Kasper, S. F., Cubała, W. J., Fagiolini, A. M., Ramos‐Quiroga, J. A., Souery, D., & Young, A. H. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1836399 · Cited by 86 · see citing works
Self-citationNeurobehavioral Abnormalities in First-Degree Relatives of Individuals With Autism
Mosconi, M. W., Kay, M., D’Cruz, A.-M., Guter, S., Kapur, K., Macmillan, C., Stanford, L. D., & Sweeney, J. A. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.87 · Cited by 84 · see citing works
Finding factors that predict treatment-resistant depression: results of a cohort study
Cepeda, M. S., Reps, J., & Ryan, P. (2018) · Depression and Anxiety · doi:10.1002/da.22774 · Cited by 80 · see citing works
Risk factors of treatment resistance in major depression: Association with bipolarity
Dudek, D., RYBAKOWSKI, J. K., Siwek, M., Pawłowski, T., Łojko, D., Roczeń, R., & Kiejna, A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.001 · Cited by 82 · see citing works
Fornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80 · see citing works
Kim, N., Huh, H.-J., & Chae, J. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.04.009 · Cited by 80 · see citing works
Woo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79 · see citing works
Schmidt, F. M., Schindler, S., Adamidis, M., Strauß, M., Tränkner, A., Trampel, R., Walter, M., Hegerl, U., Turner, R., Geyer, S., et al. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0675-8 · Cited by 76 · see citing works
Epigenetics: A missing link between early life stress and depression
Juruena, M. F., Gadelrab, R., Cleare, A. J., & Young, A. H. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110231 · Cited by 75 · see citing works
Early life stress, HPA axis, and depression.
Tofoli, S. M. D. C., Baes, C. V. W., Martins, C. M. S., & Juruena, M. F. (2011) · Psychology & Neuroscience · doi:10.3922/j.psns.2011.2.008 · Cited by 73 · see citing works
Neuropsychological changes in melancholic and atypical depression: A systematic review
Bosaipo, N. B., Foss, M. P., Young, A. H., & Juruena, M. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.014 · Cited by 78 · see citing works
Lai, C., & Hsu, Y. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000829 · Cited by 75 · see citing works
Zheng, H., Zhang, L., Li, L., Liu, P., Gao, J., Liu, X., Zou, J., Zhang, Y., Liu, J., Zhang, Z., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.009 · Cited by 75 · see citing works
Kocabas, N. A., Antonijevic, I., Faghel, C., Forray, C., Kasper, S., Lecrubier, Y., Linotte, S., Massat, I., Mendlewicz, J., Noro, M., et al. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833d18f8 · Cited by 74 · see citing works
Self-citationThe hidden third: improving outcome in treatment-resistant depression
Schlaepfer, T. E., Ågren, H., Monteleone, P., Gastó, C., Pitchot, W., Rouillon, F., Nutt, D., & Kasper, S. F. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431748 · Cited by 73 · see citing works
Self-citationSerretti, A., Calati, R., Massat, I., Linotte, S., Kasper, S. F., Lecrubier, Y., Espel, R. S., Bollen, J., Zohar, J., Berlo, J. A., et al. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832e5b0d · Cited by 73 · see citing works
Self-citationCaraci, F., Calabrese, F., Molteni, R., Bartova, L., Dold, M., Leggio, G. M., Fabbri, C., Mendlewicz, J., Racagni, G., Kasper, S. F., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014977 · Cited by 73 · see citing works
Self-citationFugger, G., Dold, M., Bartova, L., Kautzky, A., Souery, D., Mendlewicz, J., Serretti, A., Zohar, J., Montgomery, S., Frey, R., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.03.011 · Cited by 69 · see citing works
Self-citationTanti, A., & Belzung, C. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1612-z · Cited by 71 · see citing works
Bakish, D., Bose, A., Gommoll, C., Chen, C., Nunez, R., Greenberg, W. M., Liebowitz, M., & Khan, A. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130040 · Cited by 70 · see citing works
Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer
Prabhavalkar, K. S., Poovanpallil, N. B., & Bhatt, L. K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00242 · Cited by 71 · see citing works
A Genome-wide Association Meta-analysis of Preschool Internalizing Problems
Benke, K. S., Nivard, M. G., Velders, F. P., Walters, R. K., Pappa, I., Scheet, P. A., Xiao, X., Ehli, E. A., Palmer, L. J., Whitehouse, A., et al. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.12.028 · Cited by 62 · see citing works
Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D
Clark, S. L., Adkins, D. E., Åberg, K. A., Hettema, J. M., McClay, J. L., de Souza, R. P., & van den Oord, E. J. C. G. (2011) · Psychological Medicine · doi:10.1017/s003329171100239x · Cited by 67 · see citing works
A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression
Murphy, J., Sarris, J. J., & Byrne, G. J. (2017) · Depression Research and Treatment · doi:10.1155/2017/4176825 · Cited by 67 · see citing works
Dold, M., Kautzky, A., Bartova, L., Rabl, U., Souery, D., Mendlewicz, J., Porcelli, S., Serretti, A., Zohar, J., Montgomery, S., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.10.005 · Cited by 66 · see citing works
Self-citationElectroconvulsive therapy in treatment resistant depression
Subramanian, S., Lopez, R., Zorumski, C. F., & Cristancho, P. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120095 · Cited by 68 · see citing works
Nie, Z., Vairavan, S., Narayan, V. A., Ye, J., & Li, Q. S. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197268 · Cited by 62 · see citing works
- Authors
- Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., Mendlewicz, J., & Group for the Study of Resistant Depression (GSRD)
- Affiliations
- Université Libre de Bruxelles (BE)
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-07-15
- Volume
- 68
- Issue
- 07
- Pages
- 1062-1070
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1969010498
- Cited by
- 521
- References
- 22
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 26 · 2023: 30 · 2022: 26 · 2021: 54 · 2020: 35 · 2019: 46 · 2018: 31 · 2017: 22 · 2016: 23 · 2015: 25 · 2014: 27 · 2013: 29 · 2012: 21
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Les Laboratories Pierre Fabre
- Fonds De La Recherche Scientifique - FNRS
- Servier
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, major depressive disorder, antidepressant non-response, anxiety comorbidity, panic disorder, social anxiety disorder, personality disorders, suicide risk, melancholia, depression severity, hospitalization, recurrent depression, age of onset, risk factors
- MeSH terms
- Adult, Aged, Antidepressive Agents, Mental Disorders, Major Depressive Disorder, Drug Resistance, Europe, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Recurrence, Comorbidity, Treatment Failure, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
